HIV-1 lentiviral vector immunogenicity is mediated by Toll-like receptor 3 (TLR3) and TLR7. - Wikidata - awgldk - TriplyDB

HIV-1 lentiviral vector immunogenicity is mediated by Toll-like receptor 3 (TLR3) and TLR7.

HIV-1 lentiviral vector immunogenicity is mediated by Toll-like receptor 3 (TLR3) and TLR7.

http://www.wikidata.org/entity/Q33877397

about

PD-L1 co-stimulation contributes to ligand-induced T cell receptor down-modulation on CD8+ T cells Genomic HIV RNA induces innate immune responses through RIG-I-dependent sensing of secondary-structured RNA Intratumoral Lentivector-Mediated TGF-β1 Gene Downregulation As a Potent Strategy for Enhancing the Antitumor Effect of Therapy Composed of Cyclophosphamide and Dendritic Cells Immunization of mice with lentiviral vectors targeted to MHC class II+ cells is due to preferential transduction of dendritic cells in vivo Innate immune recognition and activation during HIV infection.A nonintegrative lentiviral vector-based vaccine provides long-term sterile protection against malaria Dendritic cell-directed vaccination with a lentivector encoding PSCA for prostate cancer in mice HIV-1 Tat protein binds to TLR4-MD2 and signals to induce TNF-α and IL-10.Lentivirus delivery of IL-10 to promote and sustain macrophage polarization towards an anti-inflammatory phenotype.Immunization delivered by lentiviral vectors for cancer and infectious diseases.4-1BB ligand activates bystander dendritic cells to enhance immunization in trans Generation of inducible immortalized dendritic cells with proper immune function in vitro and in vivo.Conventional dendritic cells are required for the activation of helper-dependent CD8 T cell responses to a model antigen after cutaneous vaccination with lentiviral vectors.Friend retrovirus drives cytotoxic effectors through Toll-like receptor 3 Targeting the tumor microenvironment to enhance antitumor immune responses Upregulation of BST-2/Tetherin by HIV infection in vivo.HIV-1 Tat Protein Induces Production of Proinflammatory Cytokines by Human Dendritic Cells and Monocytes/Macrophages through Engagement of TLR4-MD2-CD14 Complex and Activation of NF-κB Pathway.A TLR4 agonist synergizes with dendritic cell-directed lentiviral vectors for inducing antigen-specific immune responses Reprogrammed quiescent B cells provide an effective cellular therapy against chronic experimental autoimmune encephalomyelitis.Development of the Nanobody display technology to target lentiviral vectors to antigen-presenting cells.Synergy of TLR3 and 7 ligands significantly enhances function of DCs to present inactivated PRRSV antigen through TRIF/MyD88-NF-κB signaling pathway.Learning from the messengers: innate sensing of viruses and cytokine regulation of immunity - clues for treatments and vaccines.Toll-like receptor 7 inhibits early acute retroviral infection through rapid lymphocyte responses Systemic epigenetic response to recombinant lentiviral vectors independent of proviral integration Particle-mediated Intravenous Delivery of Antigen mRNA Results in Strong Antigen-specific T-cell Responses Despite the Induction of Type I Interferon Characterization of a third generation lentiviral vector pseudotyped with Nipah virus envelope proteins for endothelial cell transduction.Exosomes contribute to the transmission of anti-HIV activity from TLR3-activated brain microvascular endothelial cells to macrophages.Immunogenicity of targeted lentivectors.Emerging applications of lentiviral vectors in dendritic cell-based immunotherapy.MODULATING CO-STIMULATION DURING ANTIGEN PRESENTATION TO ENHANCE CANCER IMMUNOTHERAPY.Enhancing immunogenicity and cross-reactivity of HIV-1 antigens by in vivo targeting to dendritic cells.Lentiviral vectors for cancer immunotherapy and clinical applications siRNA technology in kidney transplantation: current status and future potential.Crosstalk between dendritic cell subsets and implications for dendritic cell-based anticancer immunotherapy.Lentiviral vectors in cancer immunotherapy.Dendritic Cells Cross-Present Immunogenic Lentivector-Encoded Antigen from Transduced Cells to Prime Functional T Cell Immunity.Downregulation of Stat3 in melanoma: reprogramming the immune microenvironment as an anticancer therapeutic strategy.Combination of lentivector immunization and low-dose chemotherapy or PD-1/PD-L1 blocking primes self-reactive T cells and induces anti-tumor immunity.A lentiviral vector pseudotype suitable for vaccine development.Lentiviral delivery of RNAi for in vivo lineage-specific modulation of gene expression in mouse lung macrophages.

P2860

Q28242808-658E8AAD-1CFF-404D-8DD3-060D36362A31 Q28740542-DD5D951F-6649-4A88-A2A0-4F4E8CA7AF15 Q33858506-EEE40CFE-09C6-4B1C-8BAB-C50664506E8B Q33945680-248E4CC7-52DF-41B3-A999-DAD61FFF2A11 Q33997880-50BCD482-24D3-4D29-BE9F-41D55BC746B3 Q34469817-FE78A16A-AEDD-407C-8CCF-CCFDBE696F98 Q34472125-C5FF4569-1DC8-4A63-98CE-726B63F7CD05 Q34508575-EBB6F224-BC9D-4B49-BDF0-CBFE179E4A0F Q34512267-466A6340-0F9D-45F7-92DB-3B531D4BFEA4 Q34539879-2B45295A-DF29-48C7-B994-962B8B4DCA1E Q34628912-C67A5785-998F-43E2-BBE2-B66D99FA92BB Q34693337-115C9849-C5D7-4F82-BF9B-2ABD5DCF2EBA Q34767725-A1FBA89D-6C51-4DEB-8297-C8F96132E94D Q34987791-0B2BCF0C-BAD5-430C-AB49-83E67F9F32A1 Q35176307-CDBC904F-053B-4FF6-A380-CA25B474B720 Q35275193-2362041F-C9B8-4F6D-BF8A-860DE39A4B91 Q35668299-053001D7-2FBC-4A9B-B741-E9E5752965C5 Q35990046-BEFE76D8-448B-4970-85F2-2D437B0FC9E4 Q36201277-81544A7F-F953-4409-A3BA-F713D44A7418 Q36460535-95B458BB-3B7A-4A54-A186-691A25BE1FBE Q36764982-768F02F8-60D0-4D8F-9C34-8E7642C8679A Q36807121-15999A94-66C4-4C83-B3DD-A3BEDFD5B3A3 Q36978940-F158B197-70FC-4D43-B214-D1CCF9094ADD Q37084813-F00C4132-636B-4318-9D33-4939B482D70F Q37254639-283BFF9A-02BA-4389-9775-20760BCAB9F3 Q37340427-03D3A8E1-A759-4A31-AAB6-C59B81F20149 Q37643710-CFB5A8A9-2E80-4FDB-9057-9BBC6D0DC8BC Q37718447-408680DC-D2C6-4EA7-B9C2-92B730F883CE Q37793233-13650EA4-AB0C-4FF9-8D9A-09FF1EF2412B Q38040302-D7D13D4D-0E92-43CF-8123-694AD1BDBB24 Q38059499-4C3EB723-BFCD-4169-A2FA-A8ABB7D3B6D4 Q38147100-51212AA6-9465-4115-97F6-AF47FCDA69C9 Q38191482-127EDC22-5F82-4F6B-A035-A7A07B3140A8 Q38206571-9050C1D8-310C-48B9-B74F-6FAA98F3EBF8 Q38389312-27302A0D-6091-4D0F-8291-5B48E2760AF0 Q38762699-FDDF7E4B-9657-4EA9-887C-1686A23BFE31 Q39134511-0C4BA534-3CDB-4D3F-97D2-5CE00CAA55DD Q39549328-32EE9EC0-3942-4EBE-805E-77E3B273FEA7 Q39577673-C118E3FF-CCE3-44C0-AF8D-C0433D53DA99 Q39590935-FC3179E3-E8C5-4443-A78C-0D978B97C5A3

P2860

HIV-1 lentiviral vector immunogenicity is mediated by Toll-like receptor 3 (TLR3) and TLR7.

http://www.wikidata.org/entity/Q33877397

description

2010 nî lūn-bûn

@nan

2010 թուականի Մարտին հրատարակուած գիտական յօդուած

@hyw

2010 թվականի մարտին հրատարակված գիտական հոդված

@hy

2010年の論文

@ja

2010年学术文章

@wuu

2010年学术文章

@zh-cn

2010年学术文章

@zh-hans

2010年学术文章

@zh-my

2010年学术文章

@zh-sg

2010年學術文章

@yue

name

HIV-1 lentiviral vector immuno ...... ke receptor 3 (TLR3) and TLR7.

@ast

HIV-1 lentiviral vector immuno ...... ke receptor 3 (TLR3) and TLR7.

@en

type

label

HIV-1 lentiviral vector immuno ...... ke receptor 3 (TLR3) and TLR7.

@ast

HIV-1 lentiviral vector immuno ...... ke receptor 3 (TLR3) and TLR7.

@en

prefLabel

HIV-1 lentiviral vector immuno ...... ke receptor 3 (TLR3) and TLR7.

@ast

HIV-1 lentiviral vector immuno ...... ke receptor 3 (TLR3) and TLR7.

@en

P1433

Q33877397-DF98FE92-E918-44B4-B6F4-EFB49EC446BE

P1476

Q33877397-A0D2BF6F-70F8-4413-AE8D-D67DF3A08C97

P2093

Q33877397-09CAD118-8208-463E-817E-A01ED61148DA

Q33877397-46A02548-4E22-4B16-AF80-0A3094D29D14

Q33877397-66E721F3-3B43-4DAE-BE20-F9055BBF9DA2

Q33877397-A7B244C8-48B3-4313-B054-EC4BF0411131

Q33877397-F0B23EC9-82B6-4551-8DF1-7DDA0E10509D

P2860

Q33877397-004FDB07-CBB1-4BCD-95D2-CB8626BFD48E

Q33877397-0EB0C456-C35B-4998-B454-91360477336B

Q33877397-124526BA-910B-4614-A815-4B28756A919F

Q33877397-129C67B6-DF09-4439-9A01-48074A7E1E54

Q33877397-161EFA34-B29B-434D-8C86-CF35C3AD3143

Q33877397-186122E5-82CC-44CC-A6F0-E9BA4DFCE9F2

Q33877397-22B2304A-77FF-41AE-AAB3-862CCBFCBBE2

Q33877397-285E626F-1B6F-464A-965F-0D6B1C10E7F9

Q33877397-28BB5FF3-29CB-4FC7-8574-1DE4329139EF

Q33877397-2D964150-6C31-4A59-8E7D-7F27E79BFA0F

P304

Q33877397-CCD6D0F7-84CD-45E5-AB5F-ACDD8F05D93D

P31

Q33877397-C2E0691D-4E3D-4ABD-9775-D5ACC0BAFA3C

P356

Q33877397-712F49EB-04F4-4FD9-A2C0-E7744ECE727B

P433

Q33877397-ECF35421-2509-450E-AF99-E0305C1DEDF1

P478

Q33877397-A3F60A9B-1DFB-48EF-B756-479F6F4810D5

P50

Q33877397-89F82A36-B73D-45D3-A87F-726E25033CD2

Q33877397-EF4C7F17-F240-4C26-BE7E-75DC7ECEA88F

Q33877397-EF7650D1-A025-44DA-8FA3-64008811C75B

P577

Q33877397-31513D65-2215-4B8F-ACA0-F04D79D60208

P698

Q33877397-B35326E4-1FBF-4F76-A72D-E463B60D39DE

P921

Q33877397-12ea3e9a-ac12-4199-807a-b1f1bbb2f30f

Q33877397-6C00F11F-98FB-465C-A577-90258256C275

P932

Q33877397-7E9C4127-656D-4775-8E51-3C8DEB5C01C2

P356

P1433

Journal of Virology

P1476

HIV-1 lentiviral vector immuno ...... ke receptor 3 (TLR3) and TLR7.

@en

P2093

Frederick Arce

http://www.w3.org/2001/XMLSchema#string

Katarzyna Karwacz

http://www.w3.org/2001/XMLSchema#string

Lucienne Lopes

http://www.w3.org/2001/XMLSchema#string

Mary Collins

http://www.w3.org/2001/XMLSchema#string

Sandra Van Lint

http://www.w3.org/2001/XMLSchema#string

P2860

Innate immune recognition of viral infection

Pathogen recognition and innate immunity

Small anti-viral compounds activate immune cells via the TLR7 MyD88-dependent signaling pathway

Role of adaptor TRIF in the MyD88-independent toll-like receptor signaling pathway

Taking dendritic cells into medicine

Potent induction of B- and T-cell immunity against human carcinoembryonic antigen-expressing tumors in human carcinoembryonic antigen transgenic mice mediated by direct lentivector injection.

Endocytosis of HIV-1 activates plasmacytoid dendritic cells via Toll-like receptor-viral RNA interactions

Skin-derived dendritic cells induce potent CD8(+) T cell immunity in recombinant lentivector-mediated genetic immunization.

In vivo administration of a lentiviral vaccine targets DCs and induces efficient CD8(+) T cell responses

Selective contribution of IFN-alpha/beta signaling to the maturation of dendritic cells induced by double-stranded RNA or viral infection.

P304

5627-5636

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1128/JVI.00014-10

http://www.w3.org/2001/XMLSchema#string

P433

11

http://www.w3.org/2001/XMLSchema#string

P478

84

http://www.w3.org/2001/XMLSchema#string

P50

Karine Breckpot

Marleen Keyaerts

P577

2010-03-17T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

20237085

http://www.w3.org/2001/XMLSchema#string

P921

Toll-like receptor

P932

2876620

http://www.w3.org/2001/XMLSchema#string